,,ii  #aai? ,,congress  #a/ ,session    
,s4 #dhc  ,,9 ,,! ,,s5ate ,,( ,,!       
,,unit$ ,,/ates  ,febru>y #f            
7legislative day1 ,febru>y #e71         
#bjbe,mr4 ,k+ 7= himself1 ,mr4 ,ka9e1 & 
,mr4 ,wel*7 introduc$ ! foll[+ bill2 :i*
 0 read twice & ref]r$ to ! ,committee  
on ,heal?1 ,education1 ,labor1 &        
,p5sions  ,a ,,bill  ,to am5d ! ,f$]al  
,food1 ,drug1 & ,cosmetic ,act to       
re/rict direct-to-consum] drug adv]tis+4
  #a4 ,%ort title ,?is ,act may be cit$ 
z ! ,responsibility 9 ,drug ,adv]tis+   
,act ( #bjbe4  #b4 ,direct-to-consum]   
drug adv]tis+ ,! ,f$]al ,food1 ,drug1 & 
,cosmetic ,act 7#ba ,u4,s4,c4 #cja et   
seq47 is am5d$-- 7#a7 9 section #cja    
7#ba ,u4,s4,c4 #cca71 by add+ at ! end !
 foll[+3  7jjj7 ,! conduct (            
direct-to-consum] adv]tis+ ( a drug 9   
violation ( section #ejf,m4  2 &  7#b7 9
 *apt] ,v1 by ins]t+ aft] section #ejf,l
 7#ba ,u4,s4,c4 #cefl7 ! foll[+3        
#ejf,m4 ,direct-to-consum] drug adv]tis+
  7a7 ,prohibitions  7#a7 ,fir/ #c ye>s 

7,a7 ,9 g5]al ,subject to subp>agraph   
7,b71 no p]son %all conduct             
direct-to-consum] adv]tis+1 includ+ on a
 social m$ia plat=m1 ( a drug approv$ "u
 section #eje7;c7 be=e ! end ( ! #c-ye> 
p]iod beg9n+ on ! date ( su* approval4  
7,b7 ,waiv] ,! ,secret>y may waive !    
application ( subp>agraph 7,a7 to a drug
 dur+ ! ?ird ye> ( ! #c-ye> p]iod       
describ$ 9 su* subp>agraph if-- 7i7 !   
sponsor ( ! drug submits an application 
to ! ,secret>y pursuant to subp>agraph  
7,c72 &  7ii7 ! ,secret>y1 aft] consid]+
 ! application & any accompany+         
mat]ials1 det]m9es t direct-to-consum]  
adv]tis+ ( ! drug w\ld h an affirmative 
value to public heal?4  7,c7            
,application = waiv] ,to seek a waiv] "u
 subp>agraph 7,b71 ! sponsor ( a drug   
%all submit an application to !         
,secret>y at su* "t1 9 su* mann]1 &     
conta9+ su* in=mation z ! ,secret>y may 
require4  7#b7 ,subsequ5t ye>s ,!       
,secret>y may prohibit direct-to-consum]
 adv]tis+1 includ+ on social m$ia       

plat=ms1 ( a drug dur+ ! p]iod beg9n+ at
 ! end ( ! #c-ye> p]iod describ$ 9      
p>agraph 7#a77;,a7 if ! ,secret>y       
det]m9es t ! drug has significant adv]se
 heal? effects bas$ on po/-approval     
/udies1 risk-b5efit analyses1 adv]se    
ev5t reports1 ! sci5tific lit]ature1 any
 cl9ical or obs]vational /udies1 or any 
o!r appropriate res\rce4  7b7           
,regulations ,n lat] ?an #a ye> aft] !  
date ( ! enactm5t ( ?is section1 !      
,secret>y %all revise ! regulations     
promulgat$ "u ?is ,act gov]n+ drug      
adv]tisem5ts to ! ext5t necess>y to     
implem5t ?is section4  7c7 ,rule (      
con/ruction ,?is section %all n be      
con/ru$ to dim9i% ! au?ority ( !        
,secret>y to prohibit or regulate       
direct-to-consum] adv]tis+ ( drugs1     
includ+ on social m$ia plat=ms1 "u any  
o!r provision ( law4  7d7 ,effective    
date ,?is section applies only ) respect
 to a drug approv$ "u section #eje7;c7  
on or aft] ! date t is #a ye> be=e !    
date ( enactm5t ( ?is section4  4